DPDavid Balbino Pascoal

David Balbino Pascoal

*This is an algorithmically generated author record based on publicly available information.

David Balbino Pascoal has a total of 11 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Perfil Clínico-epidemiológico de pacientes com Doença Pulmonar Obstrutiva Crônica de um Centro de Referência de Alagoas: um estudo transversal

    by David Balbino Pascoal, Isabela Macêdo de Araujo, Kartland Vieira de Luna Paiva, Thaynara Melo dos Anjos, Mariana Mendonça de Araújo Tavares, Emanuel Bonfim Claudino Pereira, Taianne Maria da Cruz Rocha, Caio Nunes de Carvalho, Tadeu Peixoto Lopes, Kelly Cristina Lira de Andrade

    Objective: To characterize the clinical-epidemiological profile – based on parameters of functional respiratory capacity, dyspnea, gravity and sociodemographic characteristics – two patients with COPD monitored at a pneumology reference center in Alagoas. Methodology: This is an observational and cross-sectional study, based on the application of a standardized questionnaire - Modified British Medical Research Council (mMRc), assessment of medical records and spirometry of patients previously diagnosed with COPD in the Pulmonology sector of the Hospital Universitário Professor Alberto Antunes (HUPAA). Results: A total of 46 patients were analyzed, obtaining a profile of female elderly (63%) who had or have smoking habits (78.3%) and other comorbidities, predominantly of cardiovascular origin. To assess the Global Initiative for Chronic Obstructive Lung Disease (GOLD) scale of patients, the mMRC was applied together with the number of annual exacerbations of the disease and classified as A (52%), B (19.5%), C (2.1%) or D (26%). As for the severity of the disease, the Forced Expiratory Value in the First Second (FEV1) was less than 50% of the predicted value in more than 70% of the patients, therefore, considered severe or very severe. Conclusion: The epidemiological profile of patients is consistent with world studies, with the exception of the prevalence of women to the detriment of men. Patients have a relatively average quality of life based on the mMRC. On the other hand, in terms of disease severity, patients with severe and very severe COPD stand out.


  • Open Access

    Analysis of the Role of Female Hormones During Infection by COVID-19

    by David Balbino Pascoal, Isabela Macêdo de Araujo, Lorenna Peixoto Lopes, Cristiane Monteiro da Cruz

    Women have metabolic, immunological, and genetic variables that ensure more protection from coronavirus infection. However, the indication of treatment for several pathologies and contraception is determined by hormones that have adverse effects and raise doubts about their use during the COVID-19 pandemic. Therefore, the present study searches women specificities and the relation between female sexual hormones and COVID-19, and reports the main recommendations in this background. To this end, a review of the literature was conducted in the main databases, auxiliary data sources, and official websites. Therefore, considering the hypercoagulability status of COVID-19, the debate about the use of contraceptives due to the relative risk of thromboembolic effects that they impose arises. However, the current available evidence, as well as the recommendations of main health organs around the world, demonstrate that the use of hormonal contraceptives must be maintained during the pandemic.